ENTRY       D10746            Mixture   Drug
NAME        Esflurbiprofen and mentha oil;
            Loqoa (TN)
COMPONENT   Esflurbiprofen [DR:D10254], Mentha oil [DR:D06461]
CLASS       Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
REMARK      Therapeutic category: 2649
            Product: D10746<JP>
EFFICACY    Analgesic, Anti-inflammatory
COMMENT     Esflurbiprofen is metabolized by CYP2C9.
METABOLISM  Enzyme: CYP2C9 [HSA:1559]
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
                2649  Others
                 D10746  Esflurbiprofen and mentha oil
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D10746  Esflurbiprofen and mentha oil
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10746
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10746
DBLINKS     PubChem: 254741707
///
